THE FUNDAMENTALS OF PHARMACOPHORE MODELING IN COMBINATORIAL CHEMISTRY*

REFERENCES

• Ehrlich P. Über den jetzigen Stand der Chemotherapie. Chem. Ber. 1909; 42: 17
   Google Scholar
• Ghose A. K., Logan M. E., Treasurywala A. M., Wang H., Wahl R. C., Tomczuk B., Gowravaram M., Jaeger E. P., Wendoloski J. J. Determination of pharmacophoric geometry for collagenase inhibitors using a novel computational method and its verification using molecular dynamics, NMR and X-ray crystallography. J. Am. Chem. Soc. 1995; 117: 4671–4682
   Web of Science ®Google Scholar
• Ghose A. K., Wendoloski J. Pharmacophore modeling: methods, experimental verifications and applications. 3D QSAR in Drug Design: Theory, Methods, and Applications, H. Kubinyi, G. Folker, Y. C. Martin. Kluwer, Dordrecht 1997
   Google Scholar
• Gund P. Pharmacophoric pattern searching and receptor mapping. Ann. Rep. Med. Chem. 1979; 14: 299–308
   Google Scholar
• Humblet C., Marshall G. R. Pharmacophore identification and receptor mapping. Ann. Rep. Med. Chem. 1980; 15: 267–276
   Google Scholar
• Klebe G. Structural alignment of molecules. 3D QSAR in Drug Design: Theory, Methods and Applications, H. Kubinyi. ESCOM, Leiden 1993; 173–199
   Google Scholar
• Martin Y. C. Pharmacophore mapping. Designing Bioactive Molecules, Y. C. Martin, P. Willett. American Chemical Society, Washington, DC 1997; 121–148
   Google Scholar
• MDL Information Systems. 1. ISIS. v 2.0.2 ed., San Leandro, CA 1997
   Google Scholar
• Pullman A. Compt. Rend. 1945; 221: 140
   Google Scholar
• Coulson C. A. Adv. Cancer. Res. 1953; 1: 1
   PubMed Web of Science ®Google Scholar
• Kier L. B. Molecular Orbital Theory in Drug Research. Academic Press, New York 1971
   Google Scholar
• Crippen G. M. Rapid calculation of coordinates from distance matrices. J. Comput. Phys. 1977; 26: 449–452
   Google Scholar
• Crippen G. M. Quantitative structure-activity relationships by distance geometry: systematic analysis of dihydrofolate reductase inhibitors. J. Med. Chem. 1980; 23: 599–606
   Google Scholar
• Crippen G. M. Why energy embedding works. J. Phys. Chem. 1987; 91: 6341–6343
   Google Scholar
• Ghose A. K., Crippen G. M. Geometrically feasible binding modes of the flexible ligand molecule at the receptor site. J. Comput. Chem. 1985; 6: 350–359
   Google Scholar
• Motoc I., Dammkoehler R. A., Marshall G. R. Three-dimensional structure activity relationships and biological receptor mapping. Mathematical and Computational Concepts in Chemistry, N. Trinajstic. Ellis Horwood, Chichester 1986; 222–251
   Google Scholar
• Sheridan R. P., Nilakantan R., Dixon J. S., Venkataraghavan R. The ensemble distance geometry: application to the nicotinic pharmacophore. J. Med. Chem. 1986; 29: 899–906
   PubMed Web of Science ®Google Scholar
• Payne A. W., Glen R. C. Molecular recognition using a binary genetic search algorithm. J. Mol. Graphics 1993; 11: 74–91
   Google Scholar
• Willett P. Similarity and Clustering in Chemical Information Systems. Research Studies Press. 1986, Letchworth
   Google Scholar
• Hahn M. Three-dimensional shape-based searching of conformationally flexible compounds. J. Chem. Inf. Comput. Sci. 1997; 33: 80–86
   Google Scholar
• Ghose A. K., Crippen G. M. Atomic physicochemical parameters for three-dimensional structure directed quantitative structure–activity relationships. I. Partition coefficients as a measure of hydrophobicity. J. Comput. Chem. 1986; 7: 565–577
   Web of Science ®Google Scholar
• Ghose A. K., Viswanadhan V. N., Wendoloski J. J. Prediction of hydrophobic properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods. J. Phys. Chem. 1998; 102: 3762–3772
   Web of Science ®Google Scholar
• Ghose A. K., Crippen G. M., Revankar G. R., McKernan P. A., Smee D. F., Robins R. K. Analysis of the in vitro antiviral activity of certain ribonucleosides against parainfluenza virus using a novel computer aided receptor modeling procedure. J. Med. Chem. 1989; 32: 746–756
   PubMedGoogle Scholar
• Viswanadhan V. N., Ghose A. K., Revankar G. R., Robins R. K. Atomic physicochemical parameters for three-dimensional structure directed quantitative structure–activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J. Chem. Inf. Comput. Sci. 1989; 29: 163–172
   Google Scholar
• Ghose A. K., Crippen G. M. Atomic physicochemical parameters for three-dimensional structure-directed quantitative structure–activity relationships. 2. Modeling dispersive and hydrophobic interactions. J. Chem. Inf. Comp. Sci. 1987; 27: 21–35
   PubMedGoogle Scholar
• AM-Technologies. Galaxy. v2.6, Manual, San Antonio, TX 1999; 2, www.amtech.com
   Google Scholar
• Ghose A. K., Viswanadhan V. N., Sanghvi Y. S., Nord L. D., Willis R. C., Revankar G. R., Robins R. K. Structural mimicry of adenosine by the antitumor agents 4-methoxy- and 4-amino-8-(β-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine as viewed by a molecular modeling method. Proc. Nat. Acad. Sci. 1989; 86: 8242–8246, USA
   PubMedGoogle Scholar
• Ghose A. K., Sangvi Y. S., Larson S. B., Revankar G. R., Robins R. K. Structural studies of the novel antitumor agents 4-amino and 4-methoxy-8(β-D-ribofuranosyl- amino) pyrimido-5,4-d]pyrimidines and their a-anomers using X-ray, 1H NMR and theoretical methods. J. Am. Chem. Soc. 1990; 112: 3622–3628
   Google Scholar
• DesJarlais R., Sheridan R. P., Seibel G. L., Dixon J. S., Kuntz I. D., Venkataraghavan R. Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. J. Med. Chem. 1988; 31: 722–729
   PubMed Web of Science ®Google Scholar
• Miranker A., Karplus M. Functionality maps of binding sites: a multiple copy simultaneous search method. Proteins 1991; 11: 29–34
   PubMed Web of Science ®Google Scholar
• Bohm H.-J. The development of a simple empirical scoring function to estimate the binding constant for a protein–ligand complex of known three-dimensional structure. J. CAD Mol. Des. 1994; 8: 243–256
   Google Scholar
• Goodsell D. S., Olson A. J. Automated docking of substrates to proteins by simulated annealing. Proteins Str. Func. Genet. 1990; 8: 195–202
   PubMed Web of Science ®Google Scholar
• Gillet V. J., Johnson A. P. Structure generation for de novo design. Designing Bioactive Molecules, Y. C. Martin, P. Willett. American Chemical Society, Washington, DC 1997; 149–174
   Google Scholar
• Ghose A. K., Viswanadhan V. N., Wendoloski J. J. Adapting structure-based drug design in the paradigm of combinatorial chemistry and high-throughput screening: an overview and new examples with important caveats for newcomers to combinatorial library design using pharmacophore models or multiple copy simultaneous search fragments. Rational Drug Design: Novel Methodology and Practical Applications, A. L. Parrill, M. R. Reddy. American Chemical Society, Washington, DC 1999; 226–238
   Google Scholar
• Livnah O., Stura E. A., Johnson D. L., Middleton S. A., Mulcahy L. S., Wrighton N. C., Dower W. J., Joliffe L. K., Wilson I. A. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 Å. Science 1996; 273: 464–471
   PubMed Web of Science ®Google Scholar
• Nicklaus M. C., Wang S., Driscol J. S., Milne G. W. Conformational changes of small molecules binding to proteins. Bioorg. Med. Chem. 1995; 3: 411–428
   PubMed Web of Science ®Google Scholar
• Bartlett P. A., Shea J. T., Telfer S. J., Waterman S. Molecular recognition in chemical and biological problems. CAVEAT: A Program to Facilitate the Structure-derived Design of Biologically Active Molecules. Special publication 78, Royal Chemical Society. 1989; 182–196
   Google Scholar
• Tschinke V., Cohen N. C. The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses. J. Med. Chem. 1993; 36: 3863–3870
   Google Scholar
• Gillet V., Johnson A. P., Mata P., Sike S., Williams P. SPROUT: a program for structure generation. J. CAD Mol. Des. 1993; 7: 127–153
   Google Scholar
• Eisen M. B., Wiley D. C., Karplus M., Hubbard R. E. HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macro-molecule binding site. Proteins 1994; 19: 199–221
   PubMed Web of Science ®Google Scholar
• Eck M. J., Pulskey S., Trub T., Harrison S. C., Shoelson S. E. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphate SHPTP2. Nature 1996; 379: 277–280
   PubMed Web of Science ®Google Scholar
• Lunney E. A., Para K. S., Rubin J. R., Humblet C., Fergus J. H., Marks J. S., Sawyer T. K. Structure-based design of a novel series of nonpeptide ligands that bind to the pp60 SRC SH2 domain. J. Am. Chem. Soc. 1997; 119: 12471
   Web of Science ®Google Scholar